NASDAQ: NUTR

NUSATRIP Inc

CIK 0002006468 · SIC 4700 · Transportation Services

Micro by assets Assets $27M as of Aug 30, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.

8-K Filed Aug 7, 2026 · Period ending Aug 3, 2026

Summary not yet generated.

8-K Filed Jun 9, 2026 · Period ending Jun 2, 2026 Red flag

NUSATRIP overhauls C-suite: removes COO, appoints new CFO after prior pick declines role

5 material changes detected. Sign up free to read the summary.

Partner

Trade NUTR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 8, 2026 · Period ending Jun 2, 2026 Red flag

NusaTrip auditor AOGB CPA resigns immediately before completing 2025 audit

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 1, 2026 · Period ending May 27, 2026 Red flag

NUSATRIP receives Nasdaq delisting notice for missing 2025 annual and Q1 2026 reports

4 material changes detected. Sign up free to read the summary.

8-K Filed May 20, 2026 · Period ending Feb 5, 2026 Critical

NUSATRIP fires CEO and CFO for cause, appoints immediate replacements

4 material changes detected. Sign up free to read the summary.

8-K Filed May 13, 2026 · Period ending May 13, 2026

NUSATRIP appoints Ade Irawan as COO, replacing departing Albert Nicolas

3 material changes detected. Sign up free to read the summary.

10-Q Filed Nov 14, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 29, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 14, 2025 (period ending Sep 30, 2025). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations

Description Three months ended September 30, 2025 (unaudited) Three months ended September 30, 2024 (unaudited) Nine months ended September 30, 2025 (unaudited) Nine months ended September 30, 2024 (unaudited)
Revenue, net
Sales online ticketing and reservation 563,150 154,785 1,275,337 538,761
Sales hotel reservation 1,014 6,672 2,976 14,678
Sales online advertisement 200,000 757,103 290,675
Sales ancillary 4,510 11,485 9,456 36,876
Software sales 504 6,721
Total revenue 768,674 173,446 2,044,872 887,711
Cost of revenue:
Software cost (4,279) (16,469)
Total cost of revenue (4,279) (16,469)
Gross income 768,674 169,167 2,044,872 871,242
Operating expenses:
Sales and marketing expenses (43,865) (37,071) (135,330) (134,926)
General and administrative expenses (1,972,196) (205,188) (3,304,486) (1,255,893)
Total operating expenses (2,016,061) (242,259) (3,439,816) (1,390,819)
Loss from operations (1,247,387) (73,092) (1,394,944) (519,577)
Other income (expense):
Interest income 1,359 418 3,287 1,773
Interest expense (55)
Loss on written-off ROU (69) (69)
Other income 244,681 32,537 847,743 33,745
Total other income (expense) 245,971 32,955 850,906 35,518
Loss before income taxes (1,001,416) (40,137) (544,038) (484,059)
Income taxes (47,839) (3,330) (47,839) (3,897)
NET LOSS (1,049,255) (43,467) (591,877) (487,956)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (85,565) (434) (12,298) (4,879)
NET LOSS ATTRIBUTABLE TO NUSATRIP INCORPORATED (963,690) (43,033) (579,579) (483,077)
Other comprehensive loss:
Net loss (1,049,255) (43,467) (591,877) (487,956)
Foreign currency translation adjustment 175,707 (476,017) 242,155 (113,864)
TOTAL OTHER COMPREHENSIVE LOSS (873,548) (519,484) (349,722) (601,820)
Net loss attributable to non-controlling interest (85,565) (434) (12,298) (4,879)
Foreign currency translation adjustment attributable to non-controlling interest 14,144 (4,571) 1,763 (1,107)
Total other comprehensive loss attributable to Nusatrip Incorporated (802,127) (514,479) (339,187) (595,834)
Net loss per share attributable to Nusatrip Incorporated:
– Basic (0.17) (0.01) (0.06) (0.12)
– Diluted (0.17) (0.01) (0.06) (0.12)
Weighted average common shares outstanding
– Basic 5,532,163 3,057,702 9,075,974 4,117,350
– Diluted 5,532,163 3,057,702 9,075,974 4,117,350

Condensed Consolidated Balance Sheets

Description September 30, 2025 (Unaudited) December 31, 2024 (Audited)
ASSETS
Current assets:
Cash and cash equivalents 5,104,182 6,934,107
Restricted cash 50,000 53,900
Accounts receivable 976,984 208,411
Amount due from related parties 9,528,747 1,138,538
Inventories 18,431 77,492
Deposits, prepayments and other receivables 11,155,320 2,655,360
Total current assets 26,833,664 11,067,808
Non-current assets:
Plant and equipment, net 63,081 88,596
Intangible assets 19,666 38,507
Right of use assets, net operating leases 87,814 115,142
Deferred tax asset 9,763 57,688
Total non-current assets 180,324 299,933
TOTAL ASSETS 27,013,988 11,367,741
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable 1,928,951 801,677
Accrued liabilities and other payables 11,094,739 12,758,278
Contract liabilities 692,652 1,032,363
Amount due to shareholder 8,568
Amounts due to related parties 2,350,223 2,366,967
Loan 116,040
Lease liabilities operating leases 54,429 105,349
Total current liabilities 16,237,034 17,073,202
Non-current liabilities:
Lease liabilities operating leases 34,690 11,076
Other payables 115,725 111,523
Total non-current liabilities 150,415 122,599
TOTAL LIABILITIES 16,387,449 17,195,801
SHAREHOLDERS’ EQUITY (DEFICIT)
Treasury stock (8) (8)
Series X Super Voting Preferred Stock, $0.0001 par value, 75,000 shares designated; 75,000 and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 8 8
Common stock, par value US$0.0001, 200,000,000 shares authorized, 19,379,168 and 14,000,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 1,938 1,400
Additional paid-in capital 18,896,252 2,092,469
Accumulated other comprehensive income 479,991 239,599
Accumulated deficit (6,872,097) (6,292,518)
Total equity attributable to Nusatrip Incorporated 12,506,084 (3,959,050)
Non-controlling interest (1,879,545) (1,869,010)
TOTAL EQUITY (DEFICIT) 10,626,539 (5,828,060)
TOTAL LIABILITIES AND EQUITY 27,013,988 11,367,741

Condensed Consolidated Statements of Cash Flows

Description Nine months ended September 30, 2025 (unaudited) Nine months ended September 30, 2024 (unaudited)
Cash flows from operating activities:
Net loss (591,877) (487,956)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities
Depreciation and amortization 45,885 83,419
Deferred tax assets 47,925 85,742
Bad debt written off 33,883
Loss from early lease termination 69
Stock to be issued professional fee 8
Change in operating assets and liabilities:
Accounts receivable (776,907) 74,825
Inventories 55,962 119,630
Deposits, prepayments and other receivables (8,606,143) 375,368
Contract liabilities (298,429) 492,068
Accounts payables 1,159,332 1,067,000
Accrued liabilities and other payables (1,144,697) 994,787
Advances to related parties (8,366,056) (88,044)
Right of use assets 103,731 89,319
Operating lease liabilities (102,599) (88,306)
Net cash (used in) provided by operating activities (18,473,804) 2,751,743
Cash flows from investing activity:
Purchase of plant, and equipment (215) (9,826)
Cash flows from financing activities:
Proceeds from issuance of shares 16,804,321
Proceed loan from issuance 116,040
Net cash generated from financing activities 16,920,361
Effect on exchange rate change on cash and cash equivalents (280,167) 12,262
NET CHANGE IN CASH AND CASH EQUIVALENTS (1,833,825) 2,754,179
CASH AND CASH EQUIVALENT AT BEGINNING OF YEAR 6,988,007 670,547
CASH AND CASH EQUIVALENT AT END OF YEAR 5,154,182 3,424,726
Supplemental disclosure of cash flow information:
Non-cash issuance of common stock by offsetting amount due 1,400
Cash paid for interest 55
Cash paid for income tax
Reconciliation to amounts on condensed unaudited consolidated balance sheets:
Cash and cash equivalents 5,104,182 3,370,626
Restricted cash 50,000 54,100
Total cash, cash equivalents and restricted cash 5,154,182 3,424,726

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗